|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Feb 28, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||||
| Cash | |||||||||||
| Prepaid expenses | |||||||||||
| Total current assets | |||||||||||
| Cash and marketable securities held in trust account | |||||||||||
| Total Assets | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued expenses | |||||||||||
| Income taxes payable | |||||||||||
| Due to related party | |||||||||||
| Promissory note – related party - extension | |||||||||||
| Promissory note – related party | |||||||||||
| Related Party | |||||||||||
| Total promissory note – related party | |||||||||||
| Total current liabilities | |||||||||||
| Warrant liabilities | |||||||||||
| Warrant liabilities | |||||||||||
| Total Liabilities | |||||||||||
| Class A common Stock subject to possible redemption, 3,208,534 and 34,500,000 shares at redemption value of approximately $10.40 and $10.11 per share as of September 30, 2023 and December 31, 2022, respectively | |||||||||||
| Stockholders’ Deficit | |||||||||||
| Common stock value | |||||||||||
| Class A Common Stock | |||||||||||
| Total common stock value | |||||||||||
| Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 0 and 8,625,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders’ Deficit | |||||||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit |
Loading...
